Article
Estrogen Receptors as Molecular Targets of Endocrine Therapy for Glioblastoma
17 Nov 2021
Abstract excerpt
Hormonal factors may participate in the development and progression of glioblastoma, the most aggressive primary tumor of the central nervous system. Many studies have been conducted on the possible involvement of estrogen receptors (ERs) in gliomas. Since there is a tendency for a reduced expression of ERs as the degree of malignancy of such tumors increases, it is important to understand the role of these...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
